Harvard Medical School (HMS) researchers have unveiled a groundbreaking AI tool, named CHARM (Cryosection Histopathology Assessment and Review Machine), designed to revolutionize the treatment of aggressive brain tumors. This cutting-edge tool can aid doctors during surgery by rapidly identifying genetic traits that guide surgical procedures.
Previously, the process of decoding the DNA of brain tumors, particularly gliomas, required days or even weeks. However, the CHARM tool swiftly studies images to extract the genetic profile of these tumors, providing detailed diagnoses to surgeons in real-time as they operate. Kun-Hsing Yu, the senior author of the research report published in the journal Med, highlights the potential benefits of this AI-driven assistance in improving patient outcomes and reducing the need for multiple surgeries.
Continue reading… “CHARM: Revolutionizing Brain Tumor Surgery with Real-Time AI Molecular Diagnostics”
